GENE ONLINE|News &
Opinion
Blog

Takeda Pharmaceutical
Deals Neuroscience
Takeda Signs New Deal with PeptiDream Spending Billions to Develop Neuromuscular Disease Drugs
2021-07-30
Trials & Approvals NSCLC
FoundationOne CDx Okayed as Companion Diagnostic for Takeda’s Lung Cancer Drug
2021-07-04
R&D Neurodegenerative Disease
Takeda to Pursue Hard-to-Drug Neurodegenerative Disease Targets with BridGene Biosciences
2021-04-01
COVID-19 Vaccine
Japan Lags Behind in COVID-19 Vaccination Goals, Looks to Hasten Approval of Second Vaccine
2021-03-15
After Five Year Oncology Alliance, Takeda Acquires Maverick to Embark on Solid Tumor Quest
2021-03-10
Trials & Approvals INTERACT Study
Neurocrine, Takeda Look to Build on Positives Post Luvadaxistat’s Schizophrenia Trial Failure
2021-03-03
Funding AAV Vectors
Ensoma Enters Gene-Editing Market with $70 Million Funding and Takeda Partnership
2021-02-12
Startups Molecular Engineering
Data-Driven Molecular Engineering Startup Partners with Takeda to Develop Next-Gen Gene Therapies
2021-01-26
NK Cell
Takeda, KSQ Join Forces to Identify NK Cell Targets For Cancer Therapies
2021-01-16
China’s Hasten Biopharmaceutic Acquires Five Non-Core Assets from Japan’s Takeda
2020-12-24
R&D TNF
Prometheus Bags $130 Million to Develop Precision Medicines for IBD Treatment
2020-11-10
COVID-19 Vaccine
Takeda Plans to Distribute 50 Million Doses of Moderna’s COVID-19 Vaccine in Japan
2020-11-01
AATD
Takeda Collaborates with Arrowhead to Overcome Inherited Disorder via RNAi Therapy
2020-10-10
Asia-Pacific CAR T-cell Therapy
Takeda Established Capabilities to Engine Cell Therapy Manufacturing
2020-09-18
Asia-Pacific Divestment
Takeda to Sell its Japan Consumer Health Business to Blackstone for $2.3B
2020-08-25
1 2 3 4 5
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top